SCHEMBL4038863

SCHEMBL4038863

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2ccoc2)Nc2ccccc2N1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
KMT2A Q03164 4/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 3/20 0.38
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
HPGD P15428 4/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4042940 0.86 TSHR (0.45) KMT2AHTTSMN1; SMN2MEN1TDP1
SCHEMBL4042732 0.82 NR1H4 (0.44) KMT2AHTTSMN1; SMN2MEN1TSHR
SCHEMBL4037453 0.82 EPHX1 (0.43) GAAKMT2AHTTSMN1; SMN2MEN1
SCHEMBL4039101 0.82 NR1H4 (0.44) KMT2AHTTSMN1; SMN2MEN1TSHR
SCHEMBL4034552 0.82 NPC1 (0.41) GAAKMT2AHTTSMN1; SMN2MEN1
SCHEMBL4040005 0.82 KMT2A (0.43) KMT2AHTTSMN1; SMN2MEN1TSHR
SCHEMBL4034516 0.81 HPGD (0.45) GAAKMT2AHTTSMN1; SMN2MEN1
SCHEMBL4043896 0.80 HTT (0.42) KMT2AHTTSMN1; SMN2MEN1TDP1
SCHEMBL4040697 0.80 NPC1 (0.44) GAAKMT2AHTTSMN1; SMN2MEN1
SCHEMBL4038973 0.80 NPC1 (0.46) GAAKMT2AHTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed